DWS related stories
All articles and analysis
Agents of changePlacement agents have faced big challenges in a rapidly changing market, but those that have evolved are thriving.
Side Letter: Arctos' $2.9bn slam dunk; Carlyle's Selwood coup; Summit's $8.35bn peakArctos is setting records with its debut sports fund. Plus: Carlyle has tapped a former CPP veteran to help with corporate M&A and Summit has capitalised on rampant appetites for growth equity. Here's today's brief, for our valued subscribers only.
The appeal of mid-life co-investmentsUnlike secondaries deals, mid-life co-investments do not require the creation of a new vehicle or resetting fund economics.
CVC set to buy Glendower amid secondaries M&A frenzyAffiliate title Secondaries Investor first reported in May 2020 that CVC had been in talks with potential candidates about building a secondaries business.
HarbourVest opens second new office this yearThe alternatives manager has opened an office in mainland Europe to tap into growing institutional and private wealth demand.
The ESG opening for fund administratorsAs ESG issues rise up managers’ agendas, fund administrators are seizing the opportunity to deliver products and services that meet their needs.
Side Letter: Genstar's $12bn; Glendower removes hard-cap; SPAC woesFundraising updates for Genstar, Glendower and Providence, plus why CFIUS could throw a spanner in the works for anyone considering a SPAC. Here's today's brief, for our valued subscribers only.
Diverse managers will bear the brunt of a flight to familiarityInvestors cannot afford to ignore a GP set that has largely outperformed industry benchmarks, even during a pandemic.
Sideletter: LACERS on liquidity; emotions in PE; 44x for ArchiMedHow does it feel to work in PE? Joyous and stressful. Plus: a supercharged healthcare exit in the mid-market and LACERS on the steep rise in capital calls. Here’s today's brief, for our valued subscribers only.
Why so emotional: How PE execs factor emotions into decision makingEmotions that are unconsciously repressed or denied could result to GPs missing out on deals and push practitioners to their limits, according to a report from DWS.